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Abstract Recent biophysical data suggest that the properties
of ceramide observed in model membranes may apply to biolog-
ical systems. In particular, the ability of ceramide to form mi-
crodomains, which coalesce into larger platforms or macrodo-
mains, appears to be important for some cellular signaling
processes. Several laboratories have now demonstrated similar
reorganization of plasma membrane sphingolipid rafts, via cer-
amide generation, into macrodomains. This event appeared nec-
essary for signaling upon activation of a speci¢c set of cell
surface receptors. In this article, we review the properties and
functions of rafts, and the role of sphingomyelinase and ceram-
ide in the biogenesis and re-modeling of these rafts. As cluster-
ing of some cell surface receptors in these domains may be
critical for signal transduction, we propose a new model for
transmembrane signal transmission.
 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The following review focuses on the mechanisms by which
ceramide can serve its second messenger role, exploring the
links between biophysical and biological data. Ceramide has
been recognized as a key signaling molecule, shown to medi-
ate cellular functions as diverse as apoptosis, cell cycle arrest,
di¡erentiation, and senescence. However, the exact mecha-
nism(s) by which ceramide performs its functions are not
completely understood. Recent biophysical data, as well as
the increasing body of work implicating ceramide signaling
in membrane rafts or microdomains, have provided clues to
show that changes in membrane structure are critical to cer-
amide function. In this article, we review the properties and
functions of membrane rafts, and the role of sphingolipids,
especially sphingomyelin and ceramide, as well as sphingo-
myelinase, in the biogenesis and maintenance of these micro-
domains. How the generation of ceramide from sphingomye-
lin alters the dynamics of rafts and in turn a¡ects various
signaling processes is discussed. In particular, this review fo-
cuses on the unique biophysical properties of ceramide to
induce membrane fusion, pore formation and the generation
of microdomains. An attempt is made to relate these proper-
ties to its biological functions, in particular to the reorganiza-
tion of raft microdomains into ceramide-enriched patches,
which then coalesce into larger platforms. As clustering of
some cell surface receptors in these macrodomains appears
critical for their signal transduction, these studies describe a
new mode of transmembrane signal transmission.
2. Ceramide: biophysical properties and biological e¡ects
A body of literature has appeared in the past decade that
has changed the perception of the plasma membrane. For
many years, the Singer^Nicholson model of the cell mem-
brane was the accepted one: it views the membrane as a ‘£uid
mosaic’ in which a homogeneous phospholipid bilayer acts
mainly as a solvent for integral proteins and as a permeability
barrier for the cell. However, the perception of the cell mem-
brane structure and dynamics has changed in the last decade
with the introduction of concepts such as lateral heterogene-
ity, lipid microdomains, and rafts. The plasma membrane is
now viewed as a heterogeneous dynamic entity, containing
various lipid domains that can assume di¡erent functional
states.
Ceramide is a sphingolipid that has gained much attention
as an important signaling molecule in vital cell processes as
diverse as apoptosis, growth arrest, senescence, di¡erentiation,
mediating an immune response, and cell cycle arrest [1^3].
Structurally, ceramides are composed of a fatty acid chain,
of varied length, saturation, and hydroxylation, bound via
an amide linkage to the amino group of a sphingoid base.
Ceramides constitute the hydrophobic backbone of all the
complex sphingolipids: sphingomyelin, cerebrosides, ganglio-
sides, and others. The fatty acid chain length of ceramide can
vary from two to 28 carbons, although C-16 to C-24 ceram-
ides are most abundant in mammalian cells. These fatty acids
are usually saturated or monounsaturated, and sometimes
may contain a hydroxyl group at the C-2 position (K-hydroxy
fatty acid) or on the terminal C atom (g-hydroxy fatty acid)
[1,2]. Ceramides are among the least polar, most hydrophobic
lipids in nature. This might explain in part their abundance in
the stratum corneum, the barrier preventing water evapora-
tion through the skin. Sphingomyelin is composed of a cer-
amide backbone with a phosphorylcholine headgroup at-
tached to the C-1 free alcohol group of ceramide.
Ceramide can be generated within a cell either through a de
novo synthesis pathway mediated by ceramide synthase, or
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through hydrolysis of cellular sphingomyelin via an acid or
neutral sphingomyelinase [1]. There is evidence to suggest that
both these pathways are involved in ceramide generation in
response to di¡erent stimuli. Both acid and neutral sphingo-
myelinases have been identi¢ed, di¡ering in their ion depen-
dence, pH optimum, or cellular localization [5]. A full descrip-
tion of the stimuli and sphingomyelinase enzymes that
regulate ceramide production is beyond the scope of this re-
view (for further information see [2,3]).
Several downstream targets for ceramide action have been
identi¢ed, and clues as to the mechanism by which ceramide
might be mediating its diverse cellular e¡ects are beginning to
emerge. Recent data from a number of laboratories have be-
gun to suggest that some of the e¡ects of ceramide are medi-
ated by its unique biophysical properties. The polar head-
group of ceramide, the amide linkage, as well as the
hydroxyl groups of sphingosine and the fatty acid chain, con-
fer onto ceramide the capacity to form extensive hydrogen
bonds in the phospholipid bilayer. The tight interactions be-
tween ceramide molecules give rise to in-plane phase separa-
tion of ceramide-rich and -poor microdomains [4]. This pro-
pensity to undergo extensive hydrogen-bonding is what
di¡erentiates sphingolipids from glycerophospholipids. While
the latter can only act as acceptors of hydrogen bonds, sphin-
golipids, such as ceramide and sphingomyelin, can act as both
acceptors and donors through their hydroxyl and amide
groups. However, ceramides and sphingomyelin di¡er in their
a⁄nity for other lipids in the membrane, namely cholesterol.
Sphingomyelin interacts very tightly with cholesterol, through
hydrogen-bonding between the C-3 hydroxyl group of choles-
terol and the sphingosine moiety of sphingomyelin, and this
serves as the basis for raft formation, as discussed in more
detail below. Ceramides, on the other hand, have very poor
a⁄nity for cholesterol and tend to separate into exclusive cer-
amide-enriched microdomains [4]. Furthermore, as a hydro-
phobic molecule, ceramide strongly favors partitioning into
bilayers, thus implying the possibility that changes in the
physical state of the membrane might play a role in ceram-
ide-mediated function. A better understanding of the proper-
ties of ceramide-containing model membranes has been pro-
vided by a number of biophysical research groups over the
past few years. These data have been invaluable in under-
standing the lipid^lipid and lipid^protein interactions that
may be determining the activities of ceramide in biologic
membranes.
Ceramides mix poorly with phospholipids in bilayers, seg-
regate into distinct high-temperature melting ceramide-en-
riched microdomains, and facilitate the lamellar^hexagonal
transition of lipids [6]. These properties a¡ect the ordering
of lipids in the membrane, tending to destabilize them and
cause e¥ux, fusion, or budding of vesicles. The recent liter-
ature has suggested that membrane fusion is critical for many
cellular processes such as membrane biogenesis and viral in-
fections [4]. In this review, we focus on three properties of
ceramide that mediate its functions: its ability to induce mem-
brane fusion/¢ssion, pore formation, and lateral separation
into microdomains.
One of the e¡ects of ceramide when added to model mem-
branes is its ability to induce membrane fusion or ¢ssion.
Ruiz-Arguello et al. [7,8] showed that treatment of large uni-
lamellar vesicles containing sphingomyelin, phosphatidyletha-
nolamine, and cholesterol with sphingomyelinase generated
ceramide within seconds, accompanied by vesicle aggregation
or e¥ux of intravesicular components. Moreover, addition of
ceramide at 5^10 mol% in phosphatidylcholine (PC)-contain-
ing vesicles reduced the time required for fusion of smaller
vesicles generated by the treatment of these PC-containing
vesicles with phospholipase C. The e¡ect of sphingomyelinase
was due to the production of ceramide which itself promoted
the lamellar to non-lamellar phase transition and induced fu-
sion. Montes et al. [9] showed that in large unilamellar vesicles
composed of di¡erent phospholipids and cholesterol, both
externally added and enzymatically produced ceramide (10
mol% of total lipid) induced release of vesicle contents. Fur-
thermore, Holopainen et al. [10] showed microscopic images
of rapid ceramide-enriched microdomain formation within 30 s
of sphingomyelinase treatment of PC/sphingomyelin large uni-
lamellar vesicles, followed by vesicular budding. These bio-
physical ¢ndings may have a biologic correlate. Zhang et al.
[16] observed that endocytic vesicles, 400 nm in diameter, are
formed in ATP-depleted macrophages when treated with
exogenous sphingomyelinase or ceramide. These vesicles are
free of caveolin or clathrin, and pinch o¡ the plasma mem-
brane to become internalized. This is in agreement with the
biophysical data that show that while sphingomyelin pro-
motes the stability of lipid bilayers, ceramide, due to its rela-
tively small polar headgroup (conical shape), induces a neg-
ative curvature, favoring vesicle formation.
Ceramide has also been shown to induce pore formation.
Siskind and Colombini [11] showed that C-2 and C-16 ceram-
ide have the capacity to form pores in model phospholipid
bilayers whereas the channel-forming capacity of dihydrocer-
amide is limited. This is an interesting ¢nding since in mam-
malian cells, dihydroceramide is also inactive [1]. The authors
argue that the pore-forming ability is due to extensive hydro-
gen-bonding capacity of ceramide, which is greatly reduced in
the dihydroceramide molecule. This might provide one mech-
anism to explain some of the biological e¡ects of ceramide:
after ceramide generation at the plasma membrane in re-
sponse to stress- or agonist-induced receptor aggregation, a
local alteration in the plasma membrane permeability barrier
might result in abnormal ion £uxes. Release of ions, such as
calcium or others, would in turn a¡ect the activity of local
enzymes, activating speci¢c local signaling cascades.
One of the e¡ects of ceramide when added to model mem-
branes is its ability to induce lateral segregation followed by
microdomain formation. Huang et al. [13] examined the struc-
ture of bilayers composed of deuterated dipalmitoyl PC and
bovine brain ceramide using nuclear magnetic resonance spec-
troscopy. They observed that the addition of ceramide in-
duced lateral phase separation of £uid phospholipid bilayers
into regions of gel, and liquid crystalline phases, where cer-
amide partitioned mostly into the gel phase. Similarly, Veiga
et al. [6] showed that in the lamellar phase, ceramides do not
mix ideally with phospholipids, giving rise to the co-existence
of domains that undergo gel^£uid transition at di¡erent tem-
peratures. Ceramide-enriched microdomains were also de-
tected in PC/phosphatidylserine mixtures using pyrene-labeled
£uorescent phospholipids to probe lateral mobility in the
membrane [15]. In these studies, atomic force microscopy re-
vealed that long chain ceramides mixed very poorly with cho-
lesterol and lateral phase separation ensued [15], indicating
that ceramide possesses the ability to spontaneously form mi-
crodomains in a glycerophospholipid bilayer. These investiga-
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tions in model membranes are reminiscent of biologic mem-
branes. It is now well known that lipids are distributed non-
randomly in the plasma membrane leading to the formation
of sub-microscopic microdomains termed rafts. Rafts are
composed mainly of sphingomyelin and cholesterol [14] (for
more detail, see Section 3), and comprise gel-like regions of
tightly packed sphingolipids, compared to the rest of the liq-
uid crystalline phospholipid bilayer.
All of this helps us understand the mechanisms by which
ceramide might signal: the generation of ceramide in response
to a stress signal or other agonist induces local changes in the
membrane environment. This in turn could a¡ect the perme-
ability and £uidity of the membrane, induce ion £uxes, in-
crease movement of proteins into or from rafts, cause confor-
mational changes in membrane-associated enzymes or
receptors, as well as alter the transbilayer movement of lipids.
The poor miscibility of ceramides and phospholipids and the
subsequent formation of ceramide-rich membrane domains
might also cause packing defects, allowing ceramide to mod-
ulate membrane-bound enzyme activity in this way. Huang et
al. [13] suggested this to be the mechanism of activation of
phospholipase A2. Ceramide generation might also change
membrane curvature, altering the three-dimensional structure
of enzymes residing in the membrane, either activating or
inhibiting them. A direct binding site for ceramide on certain
proteins is also possible, in a manner similar to diacylglycerol
binding to protein kinase C (PKC). One such paper postulates
that ceramide binds to the cysteine-rich domains of kinase
suppressor of ras (KSR) [12]. This concept is discussed further
below. In Section 3, we will explore in more detail the role of
ceramide in lipid rafts.
3. Membrane rafts
With the discovery of membrane rafts, the plasma mem-
brane is now viewed as a heterogeneous dynamic entity, or-
ganized into compositionally and functionally speci¢c do-
mains which are not static, but are rather in equilibrium
with the rest of the membrane lipids. Rafts are lateral assem-
blies of sphingolipids and cholesterol that form from the tight
hydrophobic interactions between these molecules. In this
model, sphingolipids associate laterally with one another
through weak interactions between the carbohydrate heads
of the glycosphingolipids and the hydrophobic interaction be-
tween their saturated side chains. Any voids between associ-
ated sphingolipids are ¢lled by cholesterol molecules which
also interact with the hydrophobic portion of sphingolipids
[17]. The tight interactions between cholesterol and sphingo-
myelin in the membrane, as described in Section 2, is the
driving force that segregates them from the rest of the plasma
membrane phospholipids that remain more £uid in nature
[18]. Lipid analysis has revealed that up to 70% of total cel-
lular sphingomyelin is found in rafts [23]. Treatment of cells
with cholesterol-depleting agents leads to disruption of rafts
by sequestering cholesterol and removing it from the mem-
brane, and is a technique commonly used to study the func-
tion of these rafts.
There are two types of rafts: those containing the structural
protein caveolin-1 that form caveolae, and those that lack this
protein but express two di¡erent raft-speci¢c proteins, called
£otillin-1 and 2 [19]. As caveolar and non-caveolar rafts are
highly enriched in sphingolipids and glycosphingolipids, they
are also known as glycolipid-enriched microdomains. These
rafts are also highly enriched in gangliosides, especially
GM1 which has almost exclusively been localized to them.
GM1 is the cellular cholera toxin receptor, and the toxin’s
a⁄nity for it is often used as a marker for these microdo-
mains. Rafts are resistant to solubilization with cold non-ionic
detergents, whereas the rest of the membrane lipids are solu-
ble [20]. This biochemical property has been the basis of a
technique that separates membrane rafts from the rest of the
plasma membrane on sucrose density £otation gradients. For
this reason, rafts have also been termed detergent-insoluble
glycolipid-enriched microdomains.
Non-caveolar microdomains can be 10^300 nm in size and
can assume di¡erent shapes, but are £at rather than invagi-
nated [21]. When the structural protein caveolin-1 is inserted
into them, they form the invaginated 50^100 nm £ask-shaped
structures termed caveolae. Caveolae were ¢rst discovered in
the late 1950s by Palade and Yamada [22], who at the time
observed these small £ask-shaped structures in the membrane
that looked like ‘little caves’, and hence gave them the name
caveolae [23]. Since Palade observed these structures in endo-
thelial cells, he proposed that they are involved in the uptake
of materials from the blood and their transport across the
cells, a process referred to as transcytosis. For decades, the
exact function of caveolae remained obscure. However, in the
early 1990s, and with the discovery of integral structural pro-
tein caveolin-1, scientists developed methods that allowed
them to isolate these structures and subsequently analyze their
composition and function. Caveolae have been found in sev-
eral cell types, including ¢broblasts, adipocytes, endothelial
and epithelial cells, and smooth muscle and striated muscle
cells, whereas non-caveolar rafts are believed to be ubiqui-
tously present in cells. Caveolins are palmitoylated hairpin-
like proteins and they include caveolins-1 and 2, which are
usually co-expressed in a variety of cells, and caveolin-3 which
is restricted to muscle cells.
4. Functions of rafts
It is now known that the composition and function of mem-
brane rafts can be modulated in response to a variety of
factors and stress conditions, and thus a correlation between
the physical state of the membrane and the physiological state
of the cell can be envisioned.
Many well known signaling proteins have been shown to
either reside in or be transferred into or out of rafts during the
process of signal transmission. These include the epidermal
growth factor (EGF) receptor, insulin receptor, non-receptor
tyrosine kinases (fyn and src), G proteins, Ras, nitric oxide
synthase (NOS), adenylate cyclase, PI3 kinase, several PKC
isoforms, Fas, and the tumor necrosis factor-K (TNF) recep-
tor [23]. The list of raft-associated proteins is increasing rap-
idly.
Caveolin-1 can directly interact with many of these signal-
ing molecules via a conserved 20 amino acid domain termed
the caveolin sca¡olding domain, which appears to hold mo-
lecular targets in an inactive conformation. The best charac-
terized example of this interaction is the association of cav-
eolin-1 with endothelial NOS (eNOS) [23,24]. eNOS is found
in endothelial cells and produces NO in response to various
stimuli including hormones and neurotransmitters. NO helps
dilate and relax the blood vessels allowing for easier blood
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£ow. Several groups have now shown that eNOS is bound to
caveolin-1, and that this interaction keeps it inactive [25],
whereas signals that activate eNOS induce its dissociation
from caveolin-1 [26]. Injection of mice with a peptide that
mimics caveolin-1 prevents NO production by sequestering
eNOS, and reduces in£ammation of the ears of mice treated
with mustard oil [26].
Similarly, the EGF receptor interacts with caveolin-1 within
caveolae of quiescent ¢broblasts, and rapidly exits in response
to EGF stimulation [27]. Migration out of caveolae appears to
be important for normal cellular function since mutant EGF
receptors, which are incapable of moving out of caveolae,
induce an oncogenic phenotype [27].
Alternatively, some proteins migrate into caveolae, which in
some instances may be a ceramide-regulated event. Giaccia
and co-workers showed that radiation-induced ceramide gen-
eration modulated caveolin-1 function, leading to inhibition
of phosphoinositide 3P-kinase (PI3K) that had been translo-
cated into caveolae. This e¡ect was mimicked by the addition
of C-2 ceramide exogenously [28]. Migration into rafts has
also been observed with CD-40 and the Fas receptor, for
which ceramide plays a role in signal transmission, and will
be addressed subsequently in this review [29,47].
5. Capping: de¢nition and the role of rafts in this process
Capping is a process during which cell surface receptors or
proteins aggregate on one pole of the cell after binding their
cognate ligands or agonistic antibodies [30]. This is believed to
be a prerequisite for signaling by many receptors such as the
insulin, L-selectin, EGF, Fas, and immunoglobulins, to list a
few [30]. For instance, the release of histamine from mast cells
is known to result from the rapid clustering of Fc receptors of
IgE on the cell surface.
The exact mechanism of the capping process is still poorly
understood, but it is believed that the cytoskeleton is either
directly or indirectly involved in the lateral redistribution of
surface molecules into a cap structure. The involvement of
contractile microtubules was reported many years ago. Wes-
sels et al. [31] observed an e¡ect of cytochalasin B in partially
inhibiting capping in mouse splenic lymphocytes. However, in
other cell lines, cytochalasin B promoted capping. This sug-
gests that di¡erences exist in the way micro¢laments are in-
volved in capping in di¡erent cells, and for di¡erent receptors.
The literature suggests at least two mechanisms for capping:
one which involves transmembrane linkage between surface
receptors and the sub-membrane micro¢lament and cytoskel-
etal network [30], and another which relies more on the prop-
erties of membrane microdomains to direct the interaction
with receptors [29,32].
The role of microdomains in capping is evolving. Evidence
for the role of lipids and microdomains in modulating the
capping process came long before the concept of membrane
rafts emerged, through the work of Hoover et al. [33]. Their
studies showed that as the cellular levels of cholesterol de-
creased, capping of surface immunoglobulins in murine lym-
phocytes was reduced as well. The authors proposed that the
capped proteins were found in a gel-like part of the mem-
brane, and that removal of cholesterol reduced that gel state,
increased £uidity and thus interfered with capping [33]. It is
now well established that membrane rafts are indeed in a gel-
like state. The importance of sphingolipid-enriched rafts in
receptor capping also came from the work of Macphee and
Barker [34]. These investigators showed that extended expo-
sure to C-2 ceramide resulted in trkA activation by enhancing
formation of trkA dimers, through e¡ects that involve
changes in plasmalemmal lipid composition and properties
of rafts. Concomitantly, it was shown that CD28 engagement
on the surface of T lymphocytes leads to clustering of rafts at
the site of T cell receptor (TCR) engagement, and the forma-
tion of a dense cap [35,36]. It was proposed that this process
might serve to amplify and sustain TCR-induced signaling,
resulting in increased recruitment of activating kinases to rafts
and segregation of phosphorylated substrates from phospha-
tases [37]. Direct evidence supporting this notion was pro-
vided by Janes et al. [41] who showed that aggregation of
lck and the TCR by anti-CD-3 antibodies occurred within
rafts, while CD-45, a protein tyrosine phosphatase which reg-
ulates lck activity, was found outside rafts [42]. It has even
been shown by Harder et al. that direct cross-linking of raft-
associated ganglioside GM1 by cholera toxin results in co-
capping of GM1, Thy 1, the TCR complex, and the src tyro-
sine kinase fyn, in a signaling cluster [39]. Furthermore, cap-
ping can occur in non-caveolar rafts. Stuermer et al. demon-
strated that £otillin-1 and 2 associate with the activated TCR
complex during capping [40] in neurons and Jurkat cells that
do not express caveolin-1 and lack caveolae. Activation of
some non-receptor protein tyrosine kinases and a myriad of
receptors also seem dependent on association with rafts
[43,44]. The importance of sphingolipid rafts in capping is
further emphasized by the studies of Drezewieska et al. and
Hoover et al. [33,38] who showed that disruption of rafts by
cholesterol-depleting agents, such as L-cyclodextrin or nysta-
tin, abrogated capping and signaling through the Fc-Q recep-
tor and immunoglobulin receptors, respectively.
Junge et al. [45] extended these concepts by proposing that
neutral sphingomyelinase-released ceramide was essential for
capping of L-selectin in lymphocytes. Evidence for a mecha-
nism by which rafts regulate receptor capping via the gener-
ation of ceramide was provided recently by the studies of
Cremesti et al. [29] and Grassme et al. [46,47]. These inves-
tigations, which use the Fas and CD-40 receptors as a model,
are discussed in more detail in Section 6.
In summary, these di¡erent studies suggest that rafts play a
critical role in capping and activation of distinct receptors
resulting in regulated signaling of diverse biologic outcomes,
including apoptosis, mitogenesis, and immune signaling.
6. Ceramide, sphingomyelinase and rafts
Several lines of evidence suggest that membrane rafts are
the speci¢c sites for ceramide generation in response to vari-
ous agonists and stress signals [28,29,48^50]. Liu and Ander-
son were the ¢rst to show that ceramide levels were elevated
and sphingomyelin levels decreased in the caveolae compart-
ment of human ¢broblasts in response to interleukin (IL)-1L
treatment [49]. Furthermore, this increase in ceramide was due
to the activity of a zinc-independent acid sphingomyelinase,
which was found to be enriched in those fractions. These
investigators observed that the early increase in ceramide in
response to IL-1L treatment correlated with decreased plate-
let-derived growth factor-induced thymidine uptake at 24 h.
Similarly, Bilderback et al. [51] showed that sphingomyelin is
hydrolyzed from the caveolae-enriched fractions only of NIH
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3T3 ¢broblasts in response to nerve growth factor (NGF).
These authors also showed that the low a⁄nity neurotrophin
receptor p75NTR clustered in caveolae of ¢broblasts over-ex-
pressing p75NTR and in caveolae of PC-12 pheochromocytoma
cells. Most importantly, disruption of rafts with cholesterol-
depleting agents abolished p75NTR-dependent sphingomyelin
hydrolysis and ceramide generation [52], de¢ning the impor-
tance of intact caveolae for sphingomyelinase action during
NGF signaling. Rafts have also been shown to be the sites of
ceramide generation in response to heat shock and ionizing
radiation. As stated above, Zundel et al. [28] showed that
radiation-induced ceramide generation within caveolae, via
acid sphingomyelinase (ASM), results in PI3K inhibition
through the modulation of caveolin-1 function.
The role of di¡erent sphingomyelinases in the generation of
ceramide within rafts is the subject of ongoing research. Acti-
vation of ASM vs. neutral sphingomyelinase (NSM) occurs
di¡erently in response to di¡erent stimuli [1]. ASM and NSM
have both been detected in rafts [28,53]. Cremesti et al. have
shown that ASM has the capacity to relocate rapidly from an
intracellular compartment to the plasma membrane upon Fas
stimulation [29]. Levade and his group showed that a substan-
tial pool of NSM, about 22% of the total, resides in caveolae
of human skin ¢broblasts. NSM was also detected in rafts of
¢broblasts from Niemann^Pick disease patients that lack
ASM [53]. Further, after TNF stimulation, a portion of the
TNF receptor moved into caveolae, while NSM exited, fol-
lowed by a speci¢c increase in ceramide and a decrease in
sphingomyelin in that compartment [53], suggesting that
ASM might be mediating sphingomyelin hydrolysis. The gen-
eration of ceramide in this compartment speci¢cally in re-
sponse to select agonists reinforces the idea that these micro-
domains may be crucial for the signaling of downstream
e¡ectors of ceramide action.
Recently, the role of membrane rafts in the signaling of the
Fas and CD-40 receptors has been elucidated [29,46,47,54].
Our laboratory and that of Gulbins and co-workers showed
that ceramide generation and intact rafts were essential for
optimal Fas signaling and induction of apoptosis in B and
T lymphocytes. Treatment of Jurkat T cells with cholesterol-
depleting agents prevented ceramide generation and apoptosis
induced by anti-Fas antibody for at least 9 h. Consistent with
a requirement for ceramide generation for Fas signaling,
Grassme et al. [54] showed that neutralization of surface cer-
amide with anti-ceramide antibody prevented Fas capping
and apoptosis. Cells derived from Niemann^Pick disease pa-
tients were also defective in capping and apoptosis in response
to Fas. The apoptotic response could be restored by the ad-
dition of nanomolar concentrations of exogenous C-16 ceram-
ide. Thus ceramide was capable of reversing the phenotype
without a¡ecting the genotype, restoring receptor-mediated
cell death.
Consistent with a role for membrane rafts in ceramide gen-
eration at the cell surface, ceramide could be detected by
confocal microscopy as well as £ow cytometry analysis of
non-permeabilized cells using a new polyclonal anti-ceramide
antibody, seconds after Fas stimulation. Confocal microscopy
revealed that ceramide ¢rst appears localized in patches on the
surface of cells after Fas stimulation. These patches rapidly
merged to form larger platforms which contained the Fas
receptor, ASM, and membrane raft constituents [54]. As the
addition of long chain ceramides to the surface of Jurkat cells
or generation of endogenous ceramide directly resulted in
patch formation and coalescence into larger platforms, it ap-
pears that the driving force for capping may be ceramide
itself.
Furthermore, this model of transmembrane signaling is not
restricted to Fas, as it has been shown that ASM is essential
Fig. 1. Schematic representation of the events that precede capping of the Fas receptor. Seconds after Fas engagement, ASM translocates to
the membrane and hydrolyzes sphingomyelin to ceramide within pre-formed rafts. Ceramide provides the driving force for the coalescence of
rafts, which are sub-microscopic, into patches, and then into larger platforms. Only ligated Fas receptors are capable of entering and multime-
rizing within these platforms, resulting in oligomerization of the downstream e¡ectors FADD/MORT-1 and pro-caspase-8 (not shown), an
event required for transmission of the Fas death signal.
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for the clustering of another TNF superfamily member, CD-
40 [47]. Stimulation of lymphocytes via CD-40 ligation results
in ASM translocation from intracellular stores to the mem-
brane, followed by release of extracellularly-oriented ceram-
ide, which in turn mediates CD-40 clustering in sphingolipid-
rich membrane domains. De¢ciency of ASM, destruction of
sphingolipid-rich rafts, or neutralization of surface ceramide
as with Fas prevents CD-40 clustering and CD-40-initiated
cell signaling, indicating a strict requirement for clustering
in rafts for propagation of the CD-40 signal [47]. Further-
more, the p55 TNF receptor, which is known to activate
sphingomyelinase, has also been localized to rafts, whose dis-
ruption prevented TNF-induced cell death in Jurkat cells [55].
These studies provide solid evidence that rafts are the speci¢c
sites of ceramide generation, which appears essential for cap-
ping and signaling for some TNF receptor superfamily mem-
bers.
These studies provide the basis for a proposed mechanism
for the involvement of ceramide in the capping process as
shown in Fig. 1 for Fas. Seconds after Fas engagement by
ligand or agonistic antibody, ASM translocates from an intra-
cellular pool to the outer lea£et of the plasma membrane to
hydrolyze sphingomyelin and release ceramide. This ceramide
results in the reorganization of rafts into larger platforms or
macrodomains within which Fas clusters. Fas clustering pre-
sumably facilitates oligomerization of FADD and caspase-8,
downstream Fas e¡ectors which have to oligomerize to trans-
mit the death signal. In the case of CD-40, the downstream
e¡ectors activated by the clustered receptor are those mediat-
ing CD-40 action.
These investigations begin to address the question of how
ceramide promotes transmembrane signaling. We propose
that the unique biophysical properties of ceramide discussed
in the beginning of this review regulate the process of macro-
domain formation from pre-formed microdomains. The ca-
pacity of ceramide to self-associate and its fusagenic proper-
ties may mediate the raft reorganization into macrodomains
that is required for receptor capping, and perhaps for other
signaling events. The reorganized rafts likely retain or restrict
proteins di¡erentially. In this regard, a subset of cellular pro-
teins, such as KSR, Raf, phospholipase A2, cathepsin D, pro-
tein phosphatase 2A, and PKC isoforms [2] are ceramide-ac-
tivated, some through a ceramide-binding motif, the C1B
domain [56]. Whether the C1B domain, or other as yet un-
de¢ned ceramide binding sites, targets ceramide-activated pro-
teins to regions of ceramide generation, such as rafts, is pres-
ently unknown.
7. Conclusions
Sphingomyelin^cholesterol microdomains or rafts form a
stable lipid matrix, which acts as an ordered support for re-
ceptor-mediated signaling events. Sphingolipids play essential
roles in the formation of these rafts through interaction with
cholesterol, and in raft reorganization via ceramide. We sug-
gest that the release of ceramide from sphingomyelin alters the
dynamics of these rafts, and promotes macrodomain forma-
tion. These local changes in membrane microdomains would
then drive signal transduction processes by allowing oligome-
rization of speci¢c cell surface proteins, such as ligated recep-
tors. As protein oligomerization is an almost universal
requirement for transmembrane signal transmission, we pro-
pose that the reorganization of microdomains into macrodo-
mains constitutes a new paradigm for transmitting signals
across the plasma membrane.
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